Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign Disease

Urologia Internationalis

Volumn 83, Issue 2, 2009, Pages 171-174

  Bright, Elizabeth A ^a   Manuel, Clare ^a   Goddard, Jonathan C ^a   Khan, Masood A ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Prostate; Prostate cancer; Prostate specific antigen; Transurethral resection of the prostate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER INCIDENCE; CONTROLLED STUDY; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; TRANSURETHRAL RESECTION; UNIVERSITY HOSPITAL; URINE RETENTION;

AGED; AGED, 80 AND OVER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 70349302168     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000230019     Document Type: Article

References (17)

1. info.cancerresearchuk.org/cancerstats/types/prostate/incidence/.
2. Fowler JE, Pandey P, Bigler SA, Yee DT, Kol-ski JM: Trends in diagnosis of stage T1a-b prostate cancer. J Urol 1997; 158: 1849-1852.
3. Zigeuner R, Schips L, Lipsky K, Auprich M, Salfellner M, Rehak P, Pummer K, Hubmer G: Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology 2003; 62: 883-887.
4. Martino P, Palazzo S, Battaglia M, Lucarelli G, Selvaggi FP: Incidental prostatic cancer: Repeat TURP or biopsy? Urol Int 2004; 73: 193-197.
5. Mai KT, Isotalo PA, Green J, Perkins DG, Morash C, Collins JP: Incidental prostatic adenocarcinomas and putative premalig-nant lesions in TURP specimens collected before and after the introduction of prostate-specific antigen screening. Arch Pathol Lab Med 2000; 124: 1454-1456.
6. Ornstein DK, Rao GS, Smith DS, Andriole GL: The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. J Urol 1997; 157: 880-884.
7. Yin M, Bastacky S, Chandran U, Becich MJ, Dhir R: Prevalence of incidental prostate cancer in the general population: A study of healthy organ donors. J Urol 2008; 179: 892-895.
8. Di Silverio F, Gentile V, De Matteis A, Ma-riotti G, Giuseppe V, Luigi PA, Sciarra A: Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyper-plasia: A retrospective analysis. Eur Urol 2003; 43: 164-175.
9. Descazeaud A, Peyromaure M, Salin A, Am-sellem-Ouazana D, Flam T, Viellefond A, Debre B, Zerbib M: Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era. Eur Urol 2008; 53: 355-362.
10. Roy CR, Horne D, Raife M, Pienkos E: Incidental carcinoma of prostate, long-term follow-up. Urology 1990; 36: 210-213.
11. Cheng L, Bergstralh EJ, Scherer BG, Neuman RM, Blute ML, Zincke H, Bostwick DG: Predictors of cancer progression in T1a prostate adenocarcinoma. Cancer 1999; 85: 1300-1304.
12. Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, Van Poppel H, Wolff J, Zattoni F: EAU guidelines on prostate cancer. Eur Urol 2005; 48: 546-551.
13. Egevad L, Granfors T, Karlberg L, Bergh A, Stattin P: Prognostic value of the Gleason score in prostate cancer. BJU Int 2002; 89: 538-542.
14. Antunes AA, Freire G de C, Aiello Filho D, Cury J, Srougi M: Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics (Sao Paulo) 2006; 61: 545-550.
15. Zigeuner R, Lipsky K, Riedler I, Auprich M, Schips L, Salfellner M, Pummer K, Hubmer G: Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology 2003; 62: 451-455.
16. Ishizuka O, Mimura Y, Oguchi T, Kawakami M, Nishizawa O: Importance of transition zone prostate biopsies in patients with gray-zone PSA levels undergoing the ultrasound-guided systematic ten-biopsy regimen for the first time. Urol Int 2005; 74: 23-26.
17. Robinson D, Aus G, Bak J, Gorecki T, Herder A, Rosell J, Varenhorst E: Long-term follow-up of conservatively managed incidental carcinoma of the prostate: A multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007; 41: 103-109.